Omega-3 EPA/DHA

EPA and DHA are the omega-3 fats found in oily fish and algae. They are used as supplements and, at higher doses, as prescription medicines for high triglycerides. Plant omega-3 (ALA from flax) converts to EPA and DHA only to a small extent, so it is not a direct substitute.

Omega-3s come as triglycerides, re-esterified triglycerides, ethyl esters, free fatty acids or phospholipids (krill). These forms differ in absorption, and absorption of ethyl esters improves markedly when taken with a fatty meal.

EPA and DHA are incorporated into cell membranes, where they influence membrane properties, signalling and the production of less inflammatory mediators. DHA is concentrated in the retina and brain.

Triglyceride lowering at prescription doses is well established. Cardiovascular outcome results conflict: a large trial of high-dose icosapent ethyl in treated high-risk patients reduced events, while several trials of ordinary supplement doses did not, and some studies reported more atrial fibrillation at high doses. Symptom benefit in rheumatoid arthritis and adequate DHA in pregnancy have reasonable support; a large trial in dry eye was negative.

Cell and animal studies describe membrane incorporation, eicosanoid and resolvin pathways, effects on hepatic lipid handling and retinal DHA requirements.

Evidence gap: Non-human evidence. It explains mechanisms; it does not convert into demonstrated clinical benefit.

Absorption improves with a fat-containing meal. At high intake, omega-3s mildly reduce platelet aggregation, which matters alongside anticoagulant or antiplatelet medicines and before surgery. Fishy aftertaste and reflux are common and often improve with refrigeration or a different form.

Typical supplement amounts are well tolerated, with reflux, fishy taste and loose stools most common. Higher doses raise bleeding considerations for people on blood thinners and before surgery or dental procedures, and some trials at high dose reported more atrial fibrillation. Cod liver oil also supplies vitamins A and D, so it carries additional upper-limit considerations. Fish allergy, oxidation quality and contaminants are further reasons a product is not automatically safe.

Softgels, liquids, emulsions, algal capsules and prescription products are all used. Trials describe amounts as grams of EPA and DHA per day rather than grams of fish oil.

Eating oily fish regularly is the food-first approach, with algal products for people avoiding fish. Supplements are most defensible for high triglycerides under medical care and as an adjunct in rheumatoid arthritis symptom management. They do not replace statins, blood-pressure treatment or other established cardiovascular care.

Educational example: a person taking an anticoagulant doubles their fish oil before elective surgery because a website recommended it, and the surgical team is not told. The decision factors are the actual EPA/DHA amount, the anticoagulant involved, and disclosure before procedures. Questions to ask: how much EPA and DHA am I taking, does it interact with my medicines, and should I pause it before surgery? Sustainability and sourcing are also material here: marine oils raise fishery pressure questions that algal products partly address.